Oppenheimer & CO Inc Volitionrx LTD Transaction History

Oppenheimer & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$2.88 - $4.33 $54,092 - $81,326	-18,782 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$2.89 - $4.32 $16,825 - $25,151	5,822 Added 44.92%	18,782 $73,000
Q4 2019 Feb 07, 2020	BUY	$4.28 - $5.95 $856 - $1,190	200 Added 1.57%	12,960 $61,000
Q3 2019 Oct 31, 2019	SELL	$2.97 - $6.42 $79,854 - $172,614	-26,887 Reduced 67.82%	12,760 $72,000
Q2 2019 Aug 09, 2019	BUY	$2.93 - $3.6 $4,403 - $5,410	1,503 Added 3.94%	39,647 $124,000

Q1 2019 Apr 24, 2019	SELL	$2.19 - $3.45 $1,112 - $1,752	-508 Reduced 1.31%	38,144 $124,000
Q4 2018 Jan 29, 2019	BUY	$1.7 - $2.88 $2,866 - $4,855	1,686 Added 4.56%	38,652 $70,000
Q2 2018 Aug 10, 2018	BUY	$1.88 - $2.41 $69,496 - $89,088	36,966 New	36,966 $74,000

7.96M

39K

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $36.1M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.